Search

SoHO

Substances of Human Origin (SoHO)

EHA has been involved in the evaluation and revision of EU legislation on human blood and blood components, from the start of process in 2016 to the presentation of the European Commission’s proposed Substances of Human…

Read more

EHA congratulates the Spanish Society of Hematology on its 60th anniversary

EHA President, John Gribben and member of the SEHH, María Victoria Mateos

On Thursday, June 20 the Spanish Society of Hematology (SEHH) officially celebrated its 60th anniversary with a commemorative event in Madrid.

Read more

Daratumumab, a CD38 monoclonal antibody study in advanced multiple myeloma – an open-label, dose escalation followed by open-label extension in a single-arm phase I/II study

Daratumumab is a human CD38 monoclonal antibody being tested against multiple myeloma, but it could also have potential in a broad range of other hematological diseases.

Read more

Secure European Research Funding! Sign the Petition!

 

http://www. no-cuts-on-research. eu
EHA supports European Nobel and Fields Medal prizewinners to prevent the EU research funding for 2014-2020 from being subject to budget cuts.

Read more

Challenging the safety of conformity: Better poster design to disseminate scientific knowledge fast

“Congratulations – your abstract was accepted for the upcoming EHA congress”.

Read more

Dr A van Hylckama Vlieg Announced Winner of the first EHA-ISTH Joint Fellowship

The award of EUR 72,000 over two years is intended to support the study of the physiology of bleeding, coagulation or thrombosis. Dr.

Read more

General Information

June 1, 2024
EHA2024 Congress platform opens

June 13-16, 2024
EHA2024 Madrid, Spain - In-person and live stream

Location 
IFEMA MADRID RECINTO FERIAL (Fairgrounds), Madrid, Spain

August 15, 2024
EHA2024 Congress platform closes

 
 

Scientific Program Committee (SPC) Chair
Prof Brian Huntly

Official Language
English  

EHA Congress Secretariat
INTERPLAN Congress, Meeting & Event Management…

Read more